PRGO - Perrigo Company PLC Net earnings per share (EPS TTM)
Perrigo Company plc (PRGO) management is currently restructuring internal processes to drive profitability growth, supported by developments in drug bioavailability and eco-packaging. Business revenues are based on mass supplies of over-the-counter medicines to global retail chains. The rolling annual earnings per share visualizes the financial condition, while -12.73 shows the current value of this metric.
Comprehensive metric breakdowns and analytics for Perrigo Company PLC (PRGO)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt obligations and liquidity statistics:
Debt to Equity Perrigo Company plc|PRGO - Long-Term Liabilities to Equity|Short-Term Debt to Capital Perrigo Company|PRGO - Company Cumulative Debt|Debt to Book Capitalization Ratio Perrigo Company plc|PRGO - Company Long-Term Loans and Borrowings|Company Short-Term Debt Perrigo|Quick Ratio perrigo.com
- net income and valuation multiples indicators:
PRGO - Net Financial Result|Projected Future Earnings Perrigo Company plc|PRGO - Market Cap to Net Income Ratio|Future Price to Earnings Perrigo|PRGO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Perrigo Company plc|PRGO - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Perrigo|PRGO - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months perrigo.com|PRGO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Perrigo Company plc
- revenue and sales proceeds data:
Basic company analysis:PRGO - Perrigo Company plc
Net income per share (TTM) consolidates the annual financial result by dividing total income by the number of securities to assess the business's actual profitability. Analyzing this chart of net income per share over the last 12 months, an investor can see the sensitivity of Perrigo Company plc (PRGO) margins to infant nutrition restructuring costs and production recall risks, which could offset the stability of the core drug portfolio.
Competing companies
HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Alvotech (ALVO)|LQDA (liquidia.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Galapagos GLPG|ANIP (ANI Pharmaceuticals Inc) - Earnings per one share for the last 12 months|MannKind Corp. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amphastar Corp|Pacira BioSciences (PCRX) - Earnings per share for the last twelve months|ars-pharma.com - Earnings per share for the trailing year|Earnings per share for the last twelve months Theravance Biopharma, Inc.|AQST: Earnings per share for the trailing year|Net earnings per share (EPS TTM) SCPH|Net earnings per share for the last four quarters tectonictx.com|Net earnings per share (EPS TTM) TNXP (Tonix Pharmaceuticals)|Net earnings per share for the trailing year SXT Pharmaceuticals|EPRX - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months BioHarvest Sciences, Inc.|EXOZ (Invizyne Technologies, Inc.) - Net earnings per share for the last 12 months|Oramed Pharmaceuticals Inc. - Earnings per share for the trailing year|ENTX (Entera Bio Ltd) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ipatherapeutics.com (HYFT)|Earnings per share for the last twelve months ABVC BioPharma, Inc. (ABVC)|CPIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Quantum BioPharma Limited QNTM|FGEN - Net earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Earnings per one share for the last 12 months RANI|SNYR: Net earnings per share (EPS TTM)|Rallybio (RLYB) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Lexaria Bioscience Corp|Earnings per share for the last 12 months PULM (Pulmatrix Corporation)|Net earnings per share for the last 12 months PTHL (Pheton Holdings Ltd)|APM - Net earnings per one share for the last twelve months|Lyra Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year IBO|TNFA - Earnings per share for the last twelve months|Earnings per one share for the last 12 months YCBD|PainReform Ltd. (PRFX) - Earnings per share for the last twelve months|CYTO (Altamira Therapeutics Ltd.) - Earnings per share for the last twelve months|LIPO (Lipella Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months OptiNose Inc (OPTN)|Earnings per share for the last twelve months Pieris (PIRS)|PROC: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Petros Pharmaceuticals PTPI|Earnings per share for the trailing year QLI|ACELYRIN - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year TFF Pharmaceuticals Inc. (TFFP)
